New Pharmacological Therapies for Non-Alcoholic Fatty Liver Disease

Marco A López Hernández
Additional contact information
Marco A López Hernández: Universidad Autonoma del Estado de Mexico, Ecatepec General Hospital, Mexico

Novel Approaches in Drug Designing & Development, 2019, vol. 4, issue 4, 102-104

Abstract: The Non-alcoholic Fatty Liver Disease (NAFLD) is the liver disorder most common in western countries, has a global prevalence of approximately 25% and is strongly associated to obesity and metabolic syndrome. According to the Third National Health and Nutrition Examination Survey (NHANES III) the prevalence of NAFLD is more common in obese individuals with a prevalence of 39.4% than in lean individuals with a prevalence of 7.7%. NAFLD is the hepatic manifestation of the metabolic syndrome and is defined as the accumulation of fat in the liver.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555644.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555644.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:4:y:2019:i:4:p:102-104

DOI: 10.19080/NAPDD.2019.04.555644

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().